References
- World Health Organization. Global Tuberculosis Report. World Health Organization; 2022.
- Wang MY, Sadun AA. Drug-related mitochondrial optic neuropathies. J Neuroophthalmol. 2013;33:172–178. doi:10.1097/WNO.0b013e3182901969
- Chen SC, Lin MC, Sheu SJ. Incidence and prognostic factor of ethambutol-related optic neuropathy: 10-year experience in southern Taiwan. Kaohsiung J Med Sci. 2015;31(7):358–362. doi:10.1016/j.kjms.2015.05.004
- Chamberlain PD, Sadaka A, Berry S, Lee AG. Ethambutol optic neuropathy. Curr Opin Ophthalmol. 2017;28(6):545–551. doi:10.1097/ICU.0000000000000416
- Yang HK, Park MJ, Lee JH, Lee CT, Park JS, Hwang JM. Incidence of toxic optic neuropathy with low-dose ethambutol. Int J Tuberc Lung Dis. 2016;20(2):261–264. doi:10.5588/ijtld.15.0275
- Lee EJ, Kim SJ, Choung HK, et al. Incidence and clinical features of ethambutol-induced optic neuropathy in Korea. J Neuroophthalmol. 2008;28:269–277. doi:10.1097/WNO.0b013e31818e3c6b
- Ezer N, Benedetti A, Darvish-Zargar M, Menzies D. Incidence of ethambutol related visual impairment during treatment of active tuberculosis. Int J Tuberc Lung Dis. 2013;17:447–455. doi:10.5588/ijtld.11.0766
- Mandal S, Saxena R, Dhiman R, et al. Prospective study to evaluate incidence and indicators for early detection of ethambutol toxicity. Br J Ophthalmol. 2021;105(7):1024–1028. doi:10.1136/bjophthalmol-2020-316897
- Kumar A, Sandramouli S, Verma L, et al. Ocular ethambutol toxicity: is it reversible? J Clin Neuroophthalmol. 1993;13(1):15–17.
- Woung LC, Jou JR, Liaw SL. Visual function in recovered ethambutol optic neuropathy. J Ocul Pharmacol Ther. 1995;11:411–419. doi:10.1089/jop.1995.11.411
- Tsai RK, Lee YH. Reversibility of ethambutol optic neuropathy. J Ocul Pharmacol Ther. 1997;13:473–477. doi:10.1089/jop.1997.13.473
- Melamud A, Kosmorsky GS, Lee MS. Ocular ethambutol toxicity. Mayo Clin Proc. 2003;78:1409–1411. doi:10.4065/78.11.1409
- Menon V, Jain D, Saxena R, et al. Prospective evaluation of visual function for early detection of ethambutol toxicity. Br J Ophthalmol. 2009;93:1251–1254. doi:10.1136/bjo.2008.148502
- Choi SY, Hwang JM. Optic neuropathy associated with ethambutol in Koreans. Korean J Ophthalmol. 1997;11:106–110. doi:10.3341/kjo.1997.11.2.106
- Talbert Estlin KA, Sadun AA. Risk factors for ethambutol optic toxicity. Int Ophthalmol. 2010;30:63–72. doi:10.1007/s10792-009-9293-z
- Chen HY, Lai SW, Muo CH, Chen PC, Wang IJ. Ethambutol-induced optic neuropathy: a nationwide population-based study from Taiwan. Br J Ophthalmol. 2012;96:1368–1371. doi:10.1136/bjophthalmol-2012-301870
- Ambika S, Lakshmi KP, Gopal M, Noronha OV. Visual outcomes of toxic optic neuropathy secondary to Ethambutol: a retrospective observational study from India, an endemic country. Indian J Ophthalmol. 2022;70:3388–3392. doi:10.4103/ijo.IJO_2996_21
- Steinberg EP, Tielsch JM, Schein OD, et al. The VF-14. An index of functional impairment in patients with cataract. Arch Ophthalmol. 1994;112:630–638. doi:10.1001/archopht.1994.01090170074026
- Lim SA. Ethambutol-associated optic neuropathy. Ann Acad Med Singapore. 2006;35:274–278.
- Masvidal D, Parrish RK, Lam BL. Structural-functional dissociation in presumed ethambutol optic neuropathy. J Neuroophthalmol. 2010;30(4):305–310. doi:10.1097/WNO.0b013e3181e08ecb